Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis

Completed · Phase 2 · Has a placebo group

Conditions studied: Atopic Dermatitis

In brief

To assess the efficacy and safety of MEDI9929 in adult subjects with Atopic Dermatitis

Key facts

Study ID

NCT02525094

Run by

MedImmune LLC

People needed

113

Starts

2015-08-15

Expected to finish

2016-07-15

Last updated by the study team

2018-02-15

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• AD meeting Hanifin and Rajka criteria
• Age 18-75 years inclusive at screening
• Atopic dermatitis that affects greater than/equal to 10% body surface area
• Moderate to severe AD
• Effective birth control in line with protocol details

You may not qualify if…

• Active dermatologic conditions which may confuse the diagnosis of Atopic Dermatitis
• Hepatitis B, C or HIV
• Pregnant or breastfeeding
• History of anaphylaxis following any biologic therapy
• History of clinically significant infections within 4 weeks prior to Visit 3
• Diagnosis of helminth parasitic infection within 6 months to screening
• History of Cancer except basal cell
• Receipt of any marketed or investigational biologic agent within 4 months to visit 3
• Any clinically relevant abnormal finding
• Major surgery within 8 weeks prior to Visit 1

Where it is running

• Research Site — North Miami Beach, Florida, United States
• Research Site — Tampa, Florida, United States
• Research Site — Arlington Hts, Illinois, United States
• Research Site — Carmel, Indiana, United States
• Research Site — Indianapolis, Indiana, United States
• Research Site — Berlin, New Jersey, United States
• Research Site — Charlotte, North Carolina, United States
• Research Site — Portland, Oregon, United States
• Research Site — ACT, Australia
• Research Site — Liverpool, Australia
• Research Site — Woolloongabba, Australia
• Research Site — Surrey, British Columbia, Canada
• Research Site — Barrie, Ontario, Canada
• Research Site — Québec, Quebec, Canada
• Research Site — Berlin, Germany
• Research Site — Frankfurt am Main, Germany
• Research Site — Gera, Germany
• Research Site — Hanover, Germany
• Research Site — Leipzig, Germany
• Research Site — München, Germany
• Research Site — Münster, Germany
• Research Site — Debrecen, Hungary
• Research Site — Kaposvár, Hungary
• Research Site — Miskolc, Hungary
• Research Site — Pécs, Hungary

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.